Type I, N332-glycan-dependent and Type II, N332-glycan-independent V3-glycan antibodies against HIV-1
Year: 2026
Type: article
Source: Current Opinion in HIV and AIDS
Authors: Ignacio Relano-Rodriguez, Amelia Escolano
Institutions: The Wistar Institute, University of Pennsylvania
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7204259834